← Back to Search

FAZA PET/MRI scan for Critical Limb Ischemia

N/A
Waitlist Available
Led By Patrick Veit-Haibach, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up faza pet/mri 2-3 weeks before endovascular treatment and 4-6 weeks after endovascular treatment
Awards & highlights

Study Summary

This trial will test a new imaging technique, 18F-Fluoroazomycin Arabinoside (FAZA) PET/MR, to see if it can provide more accurate diagnostic information for patients with peripheral artery disease and critical limb ischemia.

Eligible Conditions
  • Critical Limb Ischemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~faza pet/mri 2-3 weeks before endovascular treatment and 4-6 weeks after endovascular treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and faza pet/mri 2-3 weeks before endovascular treatment and 4-6 weeks after endovascular treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Validation of FAZA PET/MRI as a biomarker of hypoxia

Trial Design

1Treatment groups
Experimental Treatment
Group I: FAZA PET/MRI scanExperimental Treatment1 Intervention
PET/MRI scan using radiotracer 18F-Fluoroazomycin Arabinoside
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FAZA PET/MRI scan
2018
N/A
~40

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,479 Total Patients Enrolled
Patrick Veit-Haibach, MDPrincipal InvestigatorUniversity Health Network, Toronto
7 Previous Clinical Trials
366 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025